Giuseppe Ciaramella, President & CSO at Beam Therapeutics Inc. (BEAM), sold 154,987 shares at $104.40 ($16.6M) on 2021-06-28, disclosed to the SEC on 2021-06-30.
Open-market sale of $16.6M BEAM by President & CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.83 | 2,405 | $250K | 1.5% |
| 2 | $103.83 | 2,405 | $250K | 1.5% |
| 3 | $104.40 | 5,464 | $570K | 3.4% |
| 4 | $104.40 | 5,464 | $570K | 3.4% |
| 5 | $105.52 | 7,040 | $743K | 4.5% |
| 6 | $105.52 | 7,040 |
| $743K |
| 4.5% |
| 7 | $106.35 | 10,444 | $1.1M | 6.7% |
| 8 | $106.35 | 10,444 | $1.1M | 6.7% |
| 9 | $107.30 | 10,829 | $1.2M | 7.0% |
| 10 | $107.30 | 10,829 | $1.2M | 7.0% |
| 11 | $108.11 | 30,369 | $3.3M | 19.7% |
| 12 | $108.11 | 30,369 | $3.3M | 19.7% |
| 13 | $109.32 | 9,856 | $1.1M | 6.5% |
| 14 | $109.32 | 9,856 | $1.1M | 6.5% |
| 15 | $110.00 | 2,173 | $239K | 1.4% |
| Total | $107.31 avg | 154,987 | $16.6M | 100% |
| Filing → |
| BEAM | SELL | 2025-04-03 | $273K | — | Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |